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ole and caspofungin treatment, and we review the previous
ublished cases.
Methods: Analysis of a clinical case with zygomycosis
reakthrough infection and review of previous published
ases.
Results: To date, seven cases of immunocompromised
atient with breakthrough zygomycosis infection receiving
aspofungin were published (Table 1)
In September 2007, a 51 year old female patient was
dmitted for myelodysplastic syndrome RAEB-T, diagnosed
year before. A related allogenic hematopoietic stem cells
ransplant (HSCT) (HLA 9/10) was performed. On October
2th, the patient developed an hepatic GVHD, treated by
rednisone. The clinical evolution was good and the patient
as discharged of the hospital on October 29th on pred-
isone, cyclosporine, penicillin V, valaciclovir, voriconazole,
o-trimoxazole and folinic acid. These treatments were
topped 6 weeks later.
On January 3rd, the patient was readmitted presenting a
ebrile state and aqueous diarrhea.
An acute digestive GVHD was diagnosed and large spec-
rum antimicrobial treatment was initiated. Voriconazole
as switched to caspofungin on January 16th, due to liver
ests enzymes alteration
After 1 week of treatment, a thoracic CT scan was per-
ormed and revealed signs of pulmonary infection. Nasal
wab and bronchoalveolar lavage cultures grew with Rhi-
opus spp. The patient experienced an important clinical
orsening. Considering the severity of infectious and hema-
ologic prognosis as well as the lack of clinical response, the
hysician according with the family decided to stop aggres-
ive therapy. The patients died 10 days later.
The autopsy ﬁnding showed that the death was due to a
isseminated angioinvasive mycotic infection.
Conclusion: As reported with voriconazole, prolonged
aspofungin treatment may be a risk factor for invasive
ygomycosis infection in immunocompromised patients. This
isease must be always considered in immunocompromised
atient receiving caspofungin therapy.
oi:10.1016/j.ijid.2010.02.1754
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ranulomatous lesions in experimental Paracoccidioides
rasiliensis infection
. Burger1,∗, R.F.S. Molina2, J.V. Alves2, C.R.P. Pizzo2, A.S.
ishikaku2
Universidade Federal do Espirito Santo; Universidade de
ao Paulo, Sao Mateus e Sao Paulo, Espirito Santo e Sao
aulo, Brazil
Universidade de São Paulo, Sao Paulo, Sao Paulo, Brazil
Background: Paracoccidioidomycosis (PCM) is a systemic
ycosis, caused by the fungus Paracoccidioides brasiliensis
Pb), that affects healthy individuals living in rural areas in
atin America. There are many clinical forms of the disease;
evere forms are characterized by the presence of numer-
us disseminated granulomatous lesions, anergy in cellular
mmunity and high levels of speciﬁc antibodies, in con-
rast, mild forms have few localized granulomatous lesions,
reserved cellular immunity and low levels of speciﬁc anti-
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odies. Granuloma formation can be interpreted as a host
efense mechanism to destroy or contain Pb and avoid its
issemination.
Methods: We infected susceptible (S) and resistant
R) mice with Pb to study the granulomas. We analysed
he architecture of the granulomas and associated with
resence of morphologically preserved or destroyed Pb,
eposition of some extracellular matrix (ECM) components
collagen ﬁbers types I, II, IV, osteopontin, laminin, bigly-
an, decorin), presence of relevant cytokines to granuloma
ormation (/-IFN, TGF-$, TNF-&) and of matrix metallopro-
einases (MMP).
Results: We detected all the above mentioned elements
n the lesions. The thick ﬁbers of collagen type I, (R > S)
ay be associated with Pb infection containment; the thin
eticular ﬁbers of collagen type III may promote themicroen-
ironment for Pb-cell-ECM interactions; the marker of newly
ormed vessels collagen type IV may promote Pb dissemi-
ation and favor the inﬂux of inﬂammatory cells and the
roteoglycans biglycan and decorin, (R > S) may promote
ungal containment. The cytokines TNF-& and /-IFN, this
ater more observed in R mice may promote macrophage
ctivation, enhancing Pb killing by these cells and the
ontrol fungal dissemination; TGF-$, (S > R) may promote
eactivation and inhibition of Pb killing by macrophages,
avoring fungal dissemination and osteopontin may favor
nfection at its onset (S > R) and promote protection later
R > S). MMP-9 was detected in both S and R mice with active
nfection, eventually being involved in fungal dissemination.
Conclusion: The fate of PCM infection locally depends
f the combined effects of ECM components, which can be
imiting or permissive to Pb dissemination, and those of
ytokines, which can either activate or inactivate phago-
ytic cells, leading to Pb lysis or survival.
oi:10.1016/j.ijid.2010.02.1755
0.015
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Background: Paracoccidioidomycosis (PCM) is a deep
ycosis that presents frequent and incapacitating sequelae
ue to the development of numerous ﬁbrotic granulomatous
esions even after mycological cure, rendering the quality of
ife of the patients extremely poor.
After characterization of the granulomas developed by
usceptible (S) and resistant (R) mice infected Paracoccid-
oides brasiliensis (Pb), we evaluated the effect of drugs
hat interfere with ﬁbrosis. We treated S mice with drugs
hat interfere with ﬁbrosis: we used the cytokine -IFN
ecause, in addition to its known effect as macrophage acti-
ator, it presents direct antiﬁbrotic activity; Tetracycline
ue to its inhibitory effect on extracellular matrix (ECM) syn-
hesis in addition to its antibacterial effect and the speciﬁc
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COX-2 inhibitors Lumiracoxib and Celecoxib, because these
anti-inﬂammatory drugs increase the expression of collagens
types III and IV.
Methods: We evaluated in situ the presence of some
granuloma components such as collagen as well as of its
degradation product hydroxiprline. We also determined the
local presence of relevant cytokines to granuloma formation
and maintainance (TNF-, TGB-,  - IFN, GM-CSF and IL-12)
and also of NO, Pb with preserved or altered morphology and
the overall architecture of the granulomas.
Results: The best indicators of control of PCM as
expressed by successful local Pb lysis were the presence of
compact granulomas, delimited by a continuous deposit of
collagen type 1 arranged in concentric orientation required
to contain the fungi, and the production of high concen-
tration of cytokines IL-12 and -IFN as well as of NO. The
concentration of collagen metabolite per se was not an indi-
cator of Pb containment or dissemination.
Conclusion: Based on these parameters, we can con-
clude that therapy with -IFN and /or Tetracycline seems
promising, reducing the fungal load, increasing the produc-
tion of NO and of the stimulatory cytokines -IFN and IL-12,
decreasing that of the inhibitory cytokine TGB- and altering
the granulomas architecture towards a compact structure in
order to provide Pb containment without excessive ﬁbrosis.
doi:10.1016/j.ijid.2010.02.1756
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Cost-effectiveness analysis of the therapy for the invasive
Candidiasis in Colombia
F.J. Molina1,∗, J.A. Cortes2, H.A. Caceres3, R. Soto4, E.V.
Lemos Luengas5
1 Clinica Bolivariana, Medellin, Colombia
2 Universidad Nacional de Colombia, BOGOTA, Colombia
3 Universitat Pompeu Fabra, BOGOTA, Colombia
4 Centro Medico Imbanaco, CALI, Colombia
5 Fundacion para el Desarrollo y Apoyo en Salud Interna-
cional (FUDASAI), Bogota, Colombia
Background: Candidiasis is a nosocomial infection associ-
ated to considerable mortality and high economic impact.
The echinocandins are a new class of therapeutic medica-
tions that have shown to be effective in treating candidemia
and other forms of invasive candidiasis; however, cost of
amphotericin B dose is lower. Hypothesis: Is anidulafun-
gin (ANI) costeffective compared to caspofungin (CAS), and
amphotericin B (AMB) in the treatment of invasive candidia-
sis in non-neutropenic patients hospitalized in Intensive Care
Units (ICU) when the ﬂuconazole is not a choice, from a
third-party payer perspective.
Methods: A decision tree was designed to assess the
cost-effectiveness of the three medications and this was
validated by 2 critical care specialists and 2 infectologist.
The model simulated costs and effectiveness in a 14-week-
period. Effectiveness measure was the rate of survival and
the main outcome was saved Life Years (LYs). Clinical efﬁ-
cacy and node probabilities were obtained from a published
meta-analysis that was identiﬁed by systematic literature
review. This study estimated the direct costs associated with
invasive candidiasis treatment including antifungal drugs,
R
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ospitalization, and costs associated with adverse events.
edical costs were extracted from 7 ICUs of 3 major cities
nd drug costs were taken from a standard colombian cost-
ng source. The incremental cost per successfully treated
atient was calculated and the one way sensitivity analysis
as performed.
Results: Patients treated with ANI experienced the higher
utcomes (13.7 LYs) followed by AMB (12.1 LYs) and CAS (11.7
Ys). Mean cost per patient was lower with AMB (US$4,131)
ollowed by ANI (US$6,001) and CAS (US$6,444). Based on
CERs, ANI was the dominant therapy compared to CAS and
NI was cost-effective compared to AMB (ICER US$1.228).
Conclusion: Anidulafungin represents the cost-effective
reatment of choice when compared to caspofungin and
mphotericin B for the invasive candidiasis in Non-
eutropenic patients in Colombia.
oi:10.1016/j.ijid.2010.02.1757
0.017
yocardial infarction caused by aspergillus embolization
n a patient with cirrhosis
. Shahzad1,∗, B. Nseir2
Ochsner Medica; Center, Kenner, LA, USA
Ochsner Clinic Foundation, New Orleans, LA, USA
Background: Patient presented with ST elevation MI and
ied secondary to multiorgan failure. Autopsy revealed
ngioinvasive aspergillosis involving several organs.
Methods: Case: A 47-year-old African American male with
ast medical history of alcoholinduced cirrhosis presented
ith acute midsternal pain of 5 hours duration. Respiratory
istress developed and mechanical ventilation was required
or airways protection.
Results: Initial work up showed markedly elevated car-
iac enzymes with CPK 14000 U/L, elevated AST 800
/L, ALT 210 U/L, total bilirubin 8mg/dL, direct biliru-
in 7mg/dL, and ST segment elevation on inferior EKG
eads. Patient underwent emergent left heart catheteriza-
ion which revealed patent coronary arteries. Subsequently
ultiorgan failure resulted in decompensated shock and
atient received several vasopressors. Blood, spinal ﬂuid,
rine and sputum cultures showed no growth. Patient had
egative serology for HIV, acute viral hepatitis, syphilis,
engue fever, tularemia, herpes virus 1&2, CMV, EBV,
eptospirosis, Q fever, Lyme disease, brucellosis, and
hrlichiosis. Patient experienced intractable ventricular ﬁb-
illation which resulted in death after a 13-day hospital
tay. Autopsy report conﬁrmed disseminated angioinvasive
spergillosis involving heart, lungs, bowel, thyroid, kidneys
nd spleen in addition to complete occlusion of the poste-
ior descending artery with a fungal thrombus and multiple
ungal vegetations.
Conclusion: Discussion: Aspergillus organisms are ubiq-
itous and exposure to their conidia must be a frequent
vent. However, disease due to tissue invasion is uncommon
nd occurs primarily in the setting of immunosuppression.
isk factors for invasive aspergillosis include prolonged and
evere neutropenia, organ transplantation, AIDS and corti-
osteroid use.
